To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATAD1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
455 supporting clones for gene ATAD1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF361493 Pituitary .a 1 to 2939 1 to 2939 S160R tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2939/2939
(100 %)
3 diff
(99.9 %id)
AA259169 germinal center B cell .a 1 to 338 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
T73414 Liver .a 1760 to 2199 1 to 461       461/462
(99 %)
32 diff
(93.1 %id)
BG435845 placenta .a 2604 to 3351 1 to 747       747/747
(100 %)
8 diff
(99.0 %id)
AI097107 brain, glioblastoma (pooled) .a 2612 to 3222 613 to 3       611/613
(99 %)
0 diff
(100 %id)
DA569757 whole embryo, mainly head .a 2646 to 3500 2 to 859   capped   858/858
(100 %)
10 diff
(98.9 %id)
CB146207 Liver .a 2779 to 3417 1 to 639       639/639
(100 %)
0 diff
(100 %id)
R12287 whole brain .a 2783 to 3183 1 to 406     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 406/406
(100 %)
8 diff
(98.1 %id)
R18232 whole brain .a 2783 to 3173 1 to 401     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 401/412
(97 %)
14 diff
(96.7 %id)
R25515 whole brain .a 2783 to 3169 1 to 396       396/404
(98 %)
13 diff
(96.8 %id)
H14752 whole brain .a 2783 to 3238 1 to 462       462/464
(99 %)
18 diff
(96.2 %id)
BM806103 leiomyosarcoma, uterus .a 2785 to 3858 1 to 1075   tiling clone,   1075/1077
(99 %)
18 diff
(98.4 %id)
R20615 whole brain .a 2825 to 3169 1 to 353     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 353/381
(92 %)
13 diff
(96.6 %id)
H13396 whole brain .a 2825 to 3192 1 to 374       374/382
(97 %)
6 diff
(98.5 %id)
DA147352 amygdala .a 2898 to 3462 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA569455 whole embryo, mainly head .a 2906 to 3118 2 to 214   capped   213/213
(100 %)
4 diff
(98.2 %id)
DB130268 thymus .a 2906 to 3467 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
CA867034 Pancreas, Purified pancreatic islet .a 3006 to 3577 1 to 572     Submitted on the opposite strand 572/572
(100 %)
0 diff
(100 %id)
AA253111 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3008 to 3376 1 to 369       369/369
(100 %)
1 diff
(99.8 %id)
BF378286 uterus .a 3022 to 3501 1 to 480       480/480
(100 %)
22 diff
(95.5 %id)
AA056058 eye, retina .a 3071 to 3601 1 to 532       532/532
(100 %)
7 diff
(98.7 %id)
CD673226 eye, Iris .a 3081 to 3585 1 to 509       509/509
(100 %)
2 diff
(99.7 %id)
R84736 eye, retina .a 3095 to 3416 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
AA021513 eye, retina .a 3098 to 3438 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
BF672779 muscle (skeletal) .a 3425 to 4132 1 to 719       719/875
(82 %)
29 diff
(96.7 %id)
BQ009816 Chondrosarcoma, Left Pubic Bone .a 3465 to 4210 767 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 749/759
(98 %)
6 diff
(99.3 %id)
BQ009878 Chondrosarcoma, Left Pubic Bone .a 3504 to 4210 726 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 708/714
(99 %)
5 diff
(99.3 %id)
BE814472 breast_normal .a 3515 to 3873 1 to 363       363/363
(100 %)
6 diff
(98.4 %id)
AA730323 Ewing's sarcoma .a 3540 to 3709 1 to 170       170/170
(100 %)
2 diff
(98.9 %id)
AW794931 uterus .a 3595 to 4112 521 to 4   tiling clone,   518/521
(99 %)
0 diff
(100 %id)
DB356098 whole embryo, mainly head .a 3621 to 4205 579 to 1       579/581
(99 %)
27 diff
(95.4 %id)
AI359136 brain, glioblastoma (pooled) .a 3647 to 4203 560 to 1       560/560
(100 %)
11 diff
(98.1 %id)
AW665766 pooled .a 3682 to 4206 529 to 5       525/529
(99 %)
0 diff
(100 %id)
DB356450 whole embryo, mainly head .a 3683 to 4205 528 to 1       528/536
(98 %)
11 diff
(98.0 %id)
AA526850 normal prostate, Prostate .a 3692 to 4204 517 to 4       514/543
(94 %)
0 diff
(100 %id)
AW902148 nervous_normal .a 3729 to 3998 271 to 2       270/271
(99 %)
0 diff
(100 %id)
AI149468 placenta .a 3731 to 4205 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AI418914 brain, glioblastoma (pooled) .a 3731 to 4203 484 to 12   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 473/473
(100 %)
0 diff
(100 %id)
AW003176 pooled germ cell tumors .a 3759 to 4163 459 to 54       406/459
(88 %)
0 diff
(100 %id)
AA662766 normal prostate, Prostate .a 3779 to 4206 437 to 10       428/437
(97 %)
0 diff
(100 %id)
AI435913 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3791 to 4206 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AA158531 Pancreas .a 3793 to 4236 1 to 446       446/446
(100 %)
5 diff
(98.9 %id)
BI257410 cervical carcinoma cell line, cervix .a 3797 to 4205 1 to 413   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 413/413
(100 %)
10 diff
(97.6 %id)
AW136639   .a 3808 to 4205 415 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
AW972966   .a 3836 to 4202 367 to 1     Submitted on the opposite strand 367/376
(97 %)
34 diff
(91.0 %id)
BM665792 eye, Retina Foveal and Macular .a 3848 to 4205 370 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 358/367
(97 %)
0 diff
(100 %id)
TI_151766145   .a 3848 to 4205 91 to 452   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 362/362
(100 %)
7 diff
(98.1 %id)
T73345 Liver .a 3863 to 4205 350 to 1       350/357
(98 %)
8 diff
(97.8 %id)
H96095 melanocyte .a 3881 to 4185 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
AI474557 Prostate .a 3882 to 4204 327 to 4       324/327
(99 %)
0 diff
(100 %id)
AA912809 pooled .a 3893 to 4210 318 to 1   tiling clone,   318/318
(100 %)
1 diff
(99.7 %id)
AA988334 2 pooled tumors (clear cell type), Kidney .a 3903 to 4268 372 to 7       366/372
(98 %)
0 diff
(100 %id)
AI087824 pooled .a 3917 to 4205 310 to 22   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 289/289
(100 %)
2 diff
(99.4 %id)
AW794836 uterus .a 3920 to 4119 1 to 200       200/200
(100 %)
2 diff
(99.0 %id)
AA813856 germinal center B cell .a 3924 to 4545 611 to 8       604/617
(97 %)
0 diff
(100 %id)
BU752851 placenta .a 3930 to 4205 292 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 277/277
(100 %)
5 diff
(98.2 %id)
DB556157 hypothalamus .a 3931 to 4204 14 to 286     Submitted on the opposite strand 273/287
(95 %)
16 diff
(94.5 %id)
AA253055 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3932 to 4165 265 to 32       234/265
(88 %)
0 diff
(100 %id)
R46123 whole brain .a 3943 to 4210 291 to 14   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 278/287
(96 %)
13 diff
(95.5 %id)
EH346222   .a 4053 to 4128 1 to 76       76/76
(100 %)
0 diff
(100 %id)
AA903630 pooled germ cell tumors .a 4079 to 4206 128 to 1       128/128
(100 %)
0 diff
(100 %id)
FN052355 breast carcinoma .a 4100 to 4216 117 to 1     Submitted on the opposite strand 117/117
(100 %)
0 diff
(100 %id)
AI091241 pooled .a 4106 to 4541 452 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 436/436
(100 %)
0 diff
(100 %id)
R42168 whole brain .a 4147 to 4400 282 to 26   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 257/257
(100 %)
3 diff
(98.9 %id)
CB070215 Pancreas, Purified pancreatic islet .a 4178 to 4686 5 to 513   fully sequenced,   509/513
(99 %)
5 diff
(99.1 %id)
R12798 whole brain .a 4179 to 4400 246 to 26   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 221/221
(100 %)
1 diff
(99.6 %id)
CA772476 Pancreas, Purified pancreatic islet .a 4196 to 4994 1 to 799   tiling clone, fully sequenced,   799/799
(100 %)
0 diff
(100 %id)
AA761239 germinal center B cell .a 4308 to 4545 245 to 8       238/245
(97 %)
0 diff
(100 %id)
BG108638 retina, Retinal Pigment Epithelium sheets .a 4327 to 4560 1 to 234       234/234
(100 %)
0 diff
(100 %id)
DA941680 Spleen .a 4401 to 4938 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
FN057248 breast carcinoma .a 4429 to 4529 1 to 101       101/101
(100 %)
0 diff
(100 %id)
FN176820 breast carcinoma .a 4449 to 4527 1 to 79       79/79
(100 %)
3 diff
(96.3 %id)
BG114513 Bone, osteosarcoma, cell line .a 4506 to 4996 33 to 526       494/753
(65 %)
7 diff
(99.1 %id)
FN068341 breast carcinoma .a 4514 to 4593 1 to 78       78/79
(98 %)
7 diff
(91.2 %id)
AA158532 Pancreas .a 4535 to 4986 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
N64578 cochlea, ear .a 4579 to 5016 441 to 1       441/441
(100 %)
3 diff
(99.4 %id)
CA772176 Pancreas, Purified pancreatic islet .a 4591 to 5017 427 to 1   fully sequenced,   427/427
(100 %)
0 diff
(100 %id)
AI278144 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4599 to 5014 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AA630930   .a 4600 to 5022 425 to 1       425/425
(100 %)
8 diff
(98.2 %id)
BE045309 lymph node, lymphoma, follicular mixed small and largecell .a 4654 to 5015 363 to 1       363/363
(100 %)
3 diff
(99.2 %id)
CB069715 Pancreas, Purified pancreatic islet .a 4656 to 5017 362 to 1   fully sequenced,   362/362
(100 %)
0 diff
(100 %id)
BX103842 aorta .a 4697 to 5015 7 to 325   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 319/325
(98 %)
6 diff
(98.2 %id)
AI474276 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4716 to 5014 299 to 1       299/299
(100 %)
0 diff
(100 %id)
DA589151 lung .a 4724 to 5290 2 to 569   tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
AI719621 aorta .a 4731 to 5012 282 to 1       282/282
(100 %)
0 diff
(100 %id)
CV358220 uterus_tumor .a 5300 to 5768 1 to 477   tiling clone,   477/478
(99 %)
35 diff
(92.7 %id)
BM048689 carcinoma, cell line, Prostate .a 5338 to 5843 1 to 503   tiling clone,   503/783
(64 %)
10 diff
(98.8 %id)
BQ945487 carcinoma, cell line, Prostate .a 5340 to 6232 2 to 906   tiling clone,   905/917
(98 %)
41 diff
(95.6 %id)
T73612 Liver .a 5403 to 5660 1 to 270       270/270
(100 %)
14 diff
(94.9 %id)
BE778406 eye, retinoblastoma .a 5451 to 6221 1 to 760       760/919
(82 %)
32 diff
(96.6 %id)
BQ068637 brain, neuroblastoma, cell line .a 5589 to 6575 19 to 1023   tiling clone,   1005/1034
(97 %)
33 diff
(96.9 %id)
TI_153949345   .a 5591 to 6068 81 to 558       478/490
(97 %)
1 diff
(99.8 %id)
BF351248 head_neck .a 5658 to 5979 366 to 49       318/366
(86 %)
0 diff
(100 %id)
BF671576 muscle (skeletal) .a 5832 to 6447 1 to 625       625/1032
(60 %)
20 diff
(98.1 %id)
AW193187 adenocarcinoma, Pancreas .a 6094 to 6392 52 to 350     Submitted on the opposite strand 299/350
(85 %)
6 diff
(98.3 %id)
BX113334 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6270 to 6761 1 to 492   tiling clone,   492/492
(100 %)
0 diff
(100 %id)
BU728963 eye, optic nerve .a 6345 to 6998 653 to 2   tiling clone,   652/657
(99 %)
0 diff
(100 %id)
BQ183176 Knee, Osteoarthritic Cartilage .a 6365 to 6981 633 to 19   AAA Possibly primed on the genome, locally A rich (23/24 A in genome downstream of last aligned base) 615/615
(100 %)
2 diff
(99.7 %id)
DB333225 Spleen .a 6450 to 6981 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BM662855 eye, Retina Foveal and Macular .a 6462 to 6998 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
AA194830 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6481 to 6981 503 to 1       503/517
(97 %)
9 diff
(98.3 %id)
AI168347 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6496 to 6981 485 to 1       485/485
(100 %)
2 diff
(99.6 %id)
BQ707842 Spleen .a 6499 to 6996 1 to 502       502/502
(100 %)
12 diff
(97.7 %id)
BQ012923 placenta .a 6566 to 6981 433 to 19   AAA Possibly primed on the genome, locally A rich (23/24 A in genome downstream of last aligned base) 415/415
(100 %)
2 diff
(99.6 %id)
BE440157 Trabecular meshwork .a 6581 to 7009 431 to 3       429/431
(99 %)
0 diff
(100 %id)
BX457237 thymus .a 6581 to 6981 1 to 401   AAA Possibly primed on the genome, locally A rich (23/24 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
CF529022 placenta .a 6652 to 6998 346 to 1       346/348
(99 %)
3 diff
(99.2 %id)
AA878779 carcinoid, lung .a 6717 to 6942 225 to 1       225/225
(100 %)
1 diff
(99.6 %id)
AV694580 hepatocellular carcinoma .a 6969 to 7324 1 to 355   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 355/355
(100 %)
1 diff
(99.8 %id)
AW004844 colon .a 7305 to 7772 469 to 2   tiling clone,   468/469
(99 %)
0 diff
(100 %id)
DA274219 corpus callosum .b 1 to 571 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DB246362 uterus, tumor tissue .b 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
CN366903 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 8 to 615 1 to 608       608/608
(100 %)
2 diff
(99.7 %id)
BU187263 eye, retinoblastoma .b 21 to 861 1 to 847       847/944
(89 %)
26 diff
(97.3 %id)
DA301112 hippocampus .b 30 to 582 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AK075223 placenta .b 33 to 3066 1 to 3034 exact tiling clone, available from FLJ,   3034/3034
(100 %)
0 diff
(100 %id)
CN366900 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 33 to 689 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
NM_032810.2   .b 33 to 3066 1 to 3034 exact RefSeq,   3034/3034
(100 %)
0 diff
(100 %id)
DA037421   .b 34 to 581 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA164371 amygdala .b 34 to 599 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA833455 placenta .b 34 to 773 2 to 741   capped   740/740
(100 %)
3 diff
(99.6 %id)
DA182524 amygdala .b 212 to 786 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BC063530 Bone, osteosarcoma .b 503 to 2988 1 to 2486   available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2486/2486
(100 %)
1 diff
(100.0 %id)
AL834370 melanoma (MeWo cell line) .b 549 to 3066 1 to 2518   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2518/2518
(100 %)
0 diff
(100 %id)
BF035901 adenocarcinoma, ovary .b 614 to 1343 1 to 717       719/923
(77 %)
34 diff
(96.4 %id)
DN993180 brain, whole brain .b 622 to 1256 5 to 638       634/638
(99 %)
7 diff
(99.0 %id)
BG611706 adenocarcinoma, Prostate .b 670 to 1471 1 to 801       801/802
(99 %)
30 diff
(96.3 %id)
AK027506   .b 734 to 3066 1 to 2334   available from FLJ,   2334/2334
(100 %)
1 diff
(100.0 %id)
DA731407   .b 735 to 1522 2 to 794   capped   793/794
(99 %)
16 diff
(98.0 %id)
BP260125 heart .b 755 to 1336 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
CA489336   .b 797 to 1601 1 to 812       812/812
(100 %)
8 diff
(99.1 %id)
DA357833 subthalamic nucleus .b 835 to 1398 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BU689767 Human Lung Epithelial cells, lung .b 847 to 1521 693 to 19   AAA   675/675
(100 %)
0 diff
(100 %id)
BP228032   .b 888 to 1342 1 to 454       454/581
(78 %)
7 diff
(98.8 %id)
BC010868 Lung, large cell carcinoma .b 899 to 2812 1 to 1914   available from MGC, AAA   1914/1914
(100 %)
0 diff
(100 %id)
AI796091 Kidney .b 916 to 1520 605 to 1       605/605
(100 %)
11 diff
(98.2 %id)
BG430901 Kidney .b 917 to 1756 1 to 836       836/866
(96 %)
45 diff
(94.9 %id)
BE784612 large cell carcinoma, lung .b 920 to 1648 1 to 716   available from MGC,   716/924
(77 %)
16 diff
(98.3 %id)
DA247380 brain .b 937 to 1509 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BQ311168 breast_normal .b 959 to 1527 570 to 1       570/572
(99 %)
16 diff
(97.3 %id)
AI807844 pooled .b 962 to 1522 571 to 9       563/571
(98 %)
7 diff
(98.8 %id)
AI206748   .b 964 to 1520 560 to 6       555/570
(97 %)
13 diff
(97.8 %id)
BQ311171 breast_normal .b 971 to 1519 14 to 562       549/576
(95 %)
10 diff
(98.3 %id)
CN366899 embryonic stem cells, cell lines H1, H7, andH9 .b 1019 to 1328 25 to 334       310/334
(92 %)
6 diff
(98.3 %id)
DA229257 brain .b 1022 to 1569 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
AI810180 pooled .b 1024 to 1517 496 to 3       494/496
(99 %)
1 diff
(99.8 %id)
AI218828 pooled .b 1039 to 1522 486 to 3       484/486
(99 %)
2 diff
(99.6 %id)
TI_1948243434   .b 1041 to 1496 125 to 580   fully sequenced,   456/482
(94 %)
8 diff
(98.4 %id)
TI_1948243597   .b 1041 to 1496 119 to 574       456/598
(76 %)
9 diff
(98.5 %id)
TI_1948243760   .b 1041 to 1496 123 to 578       456/540
(84 %)
8 diff
(98.6 %id)
TI_1948243921   .b 1041 to 1496 120 to 575       456/626
(72 %)
8 diff
(98.8 %id)
EL733627 mixed .b 1042 to 1496 1 to 455       455/601
(75 %)
1 diff
(99.9 %id)
TI_157605511   .b 1056 to 1521 558 to 93   AAA   466/496
(93 %)
22 diff
(95.6 %id)
CN366901 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1060 to 1750 1 to 692       692/692
(100 %)
6 diff
(99.2 %id)
BG111206 Bone, osteosarcoma, cell line .b 1078 to 1582 1 to 512       512/999
(51 %)
16 diff
(98.4 %id)
AI765767 2 pooled tumors (clear cell type), Kidney .b 1093 to 1522 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AA707586   .b 1094 to 1522 432 to 4       429/432
(99 %)
1 diff
(99.8 %id)
AA707518   .b 1100 to 1522 425 to 3       423/426
(99 %)
2 diff
(99.6 %id)
BF353681 head_neck .b 1100 to 1426 38 to 368       332/368
(90 %)
18 diff
(95.2 %id)
BG152877 Prostate .b 1102 to 1450 349 to 1       349/349
(100 %)
3 diff
(99.2 %id)
AL525140 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1128 to 2024 1 to 897       897/897
(100 %)
20 diff
(97.8 %id)
AI336810 pooled .b 1153 to 1522 373 to 4       370/373
(99 %)
0 diff
(100 %id)
DA831706 placenta .b 1192 to 1809 10 to 625   capped   616/629
(97 %)
10 diff
(98.5 %id)
AA969676 pooled .b 1194 to 1499 306 to 1       306/410
(74 %)
7 diff
(98.3 %id)
BQ959469 leiomyosarcoma, uterus .b 1195 to 2106 12 to 924       913/924
(98 %)
19 diff
(98.0 %id)
W32662 parathyroid gland, parathyroid tumor .b 1198 to 1475 1 to 278       278/280
(99 %)
1 diff
(99.7 %id)
TI_1948243435   .b 1212 to 1496 413 to 129   fully sequenced,   285/312
(91 %)
0 diff
(100 %id)
DR763645 embryonic stem .b 1213 to 2007 8 to 802       795/802
(99 %)
6 diff
(99.3 %id)
CF529720 placenta .b 1217 to 1521 323 to 19   AAA   305/305
(100 %)
1 diff
(99.7 %id)
BM756456 Ascites, stomach .b 1219 to 1641 1 to 423       423/423
(100 %)
3 diff
(99.3 %id)
AL525139 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 2052 to 2952 897 to 1       897/897
(100 %)
46 diff
(94.9 %id)
W32476 parathyroid gland, parathyroid tumor .b 2445 to 2812 368 to 1       368/368
(100 %)
0 diff
(100 %id)
DB377501 placenta .b 2451 to 3066 607 to 1       607/618
(98 %)
21 diff
(96.7 %id)
DC412002 kidney, tumor tissue .c 1 to 560 1 to 561   tiling clone,   561/561
(100 %)
1 diff
(99.9 %id)
DC341160 thalamus .c 55 to 652 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
DC300243   .c 57 to 633 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
AU280685   .c 58 to 625 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DC410576 thymus .c 58 to 605 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DC414091 trachea .c 58 to 639 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC423006 uterus .c 58 to 601 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
DC382745 placenta .c 59 to 449 1 to 391       391/391
(100 %)
2 diff
(99.5 %id)
DC307074 cerebellum .c 60 to 619 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC315913 amygdala .c 60 to 608 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DW411978 Liver .c 60 to 293 18 to 251       234/326
(71 %)
8 diff
(97.6 %id)
DC364479   .c 60 to 543 1 to 485       485/486
(99 %)
3 diff
(99.4 %id)
DC408082 thymus .c 60 to 402 1 to 343       343/343
(100 %)
0 diff
(100 %id)
DC410753 thymus .c 63 to 585 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
DC415183 trachea .c 63 to 532 1 to 470       470/470
(100 %)
0 diff
(100 %id)
DC329229 corpus callosum .c 69 to 621 1 to 553       553/554
(99 %)
6 diff
(99.0 %id)
BP260778 small intestine .c 69 to 650 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DC330457 hippocampus .c 71 to 628 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
DC334084 hippocampus .c 71 to 342 1 to 272       272/272
(100 %)
0 diff
(100 %id)
CD688548 normal nasopharynx .c 71 to 441 23 to 393       371/393
(94 %)
6 diff
(98.5 %id)
DC364465   .c 71 to 620 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC367954   .c 71 to 604 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
BP313767 mammary gland .c 71 to 653 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
BP359404 mammary gland .c 71 to 652 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC414187 trachea .c 71 to 532 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
DC329989 hippocampus .c 73 to 635 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
DC344997 colon .c 73 to 644 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DC425391   .c 73 to 623 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
DC296553 synovial membrane tissue from rheumatioidarthritis .c 73 to 613 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
DC412167 kidney, tumor tissue .c 73 to 647 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
DC344733 colon .c 82 to 653 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AK304297 trachea .c 290 to 1567 1 to 1278   tiling clone,   1278/1278
(100 %)
1 diff
(100.0 %id)
DC417731 trachea .c 290 to 889 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
BG702987 brain, hippocampus .d 1 to 676 1 to 675   tiling clone,   675/675
(100 %)
6 diff
(99.2 %id)
DB442238 testis .d 6 to 308 1 to 303       303/336
(90 %)
13 diff
(96.2 %id)
DB470301 hippocampus .d 6 to 443 1 to 439       439/439
(100 %)
1 diff
(99.8 %id)
BQ189496 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 464 to 1106 1 to 643   tiling clone, fully sequenced, AAA   643/643
(100 %)
3 diff
(99.6 %id)
TI_151734001   .d 466 to 1106 721 to 82   tiling clone, AAA   640/886
(72 %)
19 diff
(97.9 %id)
CK300495 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 835 to 1106 290 to 19   fully sequenced, AAA   272/272
(100 %)
0 diff
(100 %id)
DC417817 trachea .e 1 to 597 1 to 599   tiling clone,   599/599
(100 %)
3 diff
(99.5 %id)
DR001613 fetal brain .e 3 to 830 1 to 826       826/828
(99 %)
9 diff
(99.0 %id)
DC346476 tongue, tumor tissue .e 5 to 474 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BG702636 brain, hippocampus .e 6 to 700 1 to 693       693/693
(100 %)
17 diff
(97.6 %id)
BI562244 testis .e 15 to 721 1 to 701       701/705
(99 %)
15 diff
(97.9 %id)
BX403702 placenta .e 17 to 980 1 to 877       877/877
(100 %)
1 diff
(99.9 %id)
CF995142 Human Placenta, placenta .e 18 to 798 29 to 817       787/820
(95 %)
14 diff
(98.3 %id)
TI_44349846   .e 18 to 721 78 to 775       698/779
(89 %)
21 diff
(97.4 %id)
DA283171 corpus callosum .e 20 to 612 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA424731   .e 20 to 582 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA825096 pericardium .e 20 to 501 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
DB217726 trachea .e 20 to 507 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
BP215804 corpus callosum .e 21 to 602 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BJ993577 hepatoblastoma .e 21 to 521 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BP276283 Kidney .e 21 to 601 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP338931 Spleen .e 21 to 600 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA008157   .e 22 to 571 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA044409 bladder .e 22 to 590 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA138134 alzheimer cortex .e 22 to 575 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA154711 amygdala .e 22 to 493 2 to 473   capped   472/472
(100 %)
4 diff
(99.2 %id)
DA169524 amygdala .e 22 to 515 2 to 496   capped   495/495
(100 %)
1 diff
(99.8 %id)
DA183612 amygdala .e 22 to 570 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA225277 brain .e 22 to 588 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA307197 hippocampus .e 22 to 485 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA351419 substantia nigra .e 22 to 572 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA424515   .e 22 to 583 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA488255 brain .e 22 to 515 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA488626 brain .e 22 to 589 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA715513   .e 22 to 589 2 to 570   capped   569/570
(99 %)
2 diff
(99.7 %id)
DA748383   .e 22 to 583 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA827830 pericardium .e 22 to 595 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB146027 thymus .e 22 to 586 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB211946 trachea .e 22 to 552 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
DB241436 trachea .e 22 to 616 2 to 597   capped   596/596
(100 %)
3 diff
(99.5 %id)
DA097282 cerebellum .e 25 to 582 17 to 576   capped   560/575
(97 %)
8 diff
(98.7 %id)
DA266047 caudate nucleus .e 25 to 498 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA020220   .e 26 to 585 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA062048 cerebellum .e 26 to 589 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA296832 hippocampus .e 26 to 604 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA643410   .e 29 to 563 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
AA304993 colon .e 31 to 459 1 to 429       429/429
(100 %)
0 diff
(100 %id)
AV650317 corresponding non cancerous liver tissue .e 31 to 437 1 to 407     Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
AA379726 skin .e 33 to 364 1 to 334       334/334
(100 %)
3 diff
(99.2 %id)
BC073998 Peripheral Nervous System, sympathetictrunk .e 40 to 2816 1 to 2777 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2777/2777
(100 %)
0 diff
(100 %id)
BQ890814 sciatic nerve .e 42 to 558 1 to 521       521/1234
(42 %)
15 diff
(98.8 %id)
BG115651 duodenal adenocarcinoma, cell line, small intestine .e 47 to 730 7 to 685       679/907
(74 %)
28 diff
(97.0 %id)
CN366902 embryonic stem cells, DMSO-treated H9 cellline .e 52 to 608 1 to 557       557/557
(100 %)
5 diff
(99.2 %id)
DA342185 substantia nigra .e 98 to 662 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CN366898 embryonic stem cells, cell lines H1, H7, andH9 .e 130 to 893 1 to 761       761/764
(99 %)
6 diff
(99.3 %id)
BF794837 lymph, lymphoma, cell line .e 145 to 826 1 to 688       688/1055
(65 %)
17 diff
(98.4 %id)
BQ694273 adipose .e 147 to 832 1 to 685       685/688
(99 %)
3 diff
(99.6 %id)
DA645538   .e 158 to 750 2 to 596   capped   595/595
(100 %)
4 diff
(99.4 %id)
DB185777 liver, tumor tissue .e 183 to 750 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA249270 brain .e 205 to 803 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA019736   .e 244 to 816 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA186825 amygdala .e 314 to 856 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AW504019 lymph .e 364 to 893 4 to 533       530/534
(99 %)
9 diff
(98.4 %id)
TI_154160091   .e 369 to 899 87 to 617       531/553
(96 %)
6 diff
(99.0 %id)
BF107405 placenta .e 437 to 1065 1 to 616       613/640
(95 %)
23 diff
(96.5 %id)
BP428721   .e 458 to 832 1 to 375       375/375
(100 %)
4 diff
(99.0 %id)
AW082682 pooled .e 530 to 872 345 to 3       343/346
(99 %)
20 diff
(94.3 %id)
FN128894 breast carcinoma .e 688 to 775 87 to 1     Submitted on the opposite strand 87/87
(100 %)
1 diff
(98.9 %id)
EH323051   .e 751 to 822 1 to 71       71/71
(100 %)
1 diff
(98.6 %id)
AW296739   .e 976 to 1417 461 to 20       442/469
(94 %)
2 diff
(99.6 %id)
T78284 whole brain .e 978 to 1382 1 to 410       410/478
(85 %)
11 diff
(97.7 %id)
BE814870 breast_normal .e 979 to 1399 427 to 9       419/428
(97 %)
16 diff
(96.3 %id)
F06779 brain, total brain .e 979 to 1291 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BX349036 Placenta Cot 25-normalized .e 1024 to 1610 1 to 586       586/643
(91 %)
12 diff
(98.2 %id)
BF680249 Prostate .e 1024 to 1613 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
BE003073 breast_normal .e 1093 to 1455 366 to 8     Submitted on the opposite strand 359/366
(98 %)
0 diff
(100 %id)
AW994403 breast_normal .e 1145 to 1841 697 to 3     Submitted on the opposite strand 695/699
(99 %)
0 diff
(100 %id)
BF216662 brain, glioblastoma .e 1168 to 1828 1 to 660       660/774
(85 %)
26 diff
(96.7 %id)
BF970767 adrenal cortex carcinoma, cell line, adrenal gland .e 1195 to 1902 1 to 701       701/712
(98 %)
26 diff
(96.4 %id)
N83750   .e 1219 to 1446 1 to 226       226/226
(100 %)
4 diff
(98.3 %id)
N44865.
matches multiple genes
melanocyte .e 1229 to 1611 1 to 383     Submitted on the opposite strand, also hits gene ERBB2 383/383
(100 %)
1 diff
(99.8 %id)
AV724197 hypothalamus .e 1244 to 1654 1 to 399       399/402
(99 %)
13 diff
(96.8 %id)
R16042 whole brain .e 1258 to 1695 1 to 446       446/446
(100 %)
11 diff
(97.6 %id)
CX865914 embryonic stem .e 1273 to 1913 1 to 641       641/641
(100 %)
0 diff
(100 %id)
BF678412 Prostate .e 1276 to 1817 1 to 544       544/790
(68 %)
8 diff
(99.0 %id)
AA369840 Prostate .e 1300 to 1579 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AA370558 Prostate .e 1300 to 1558 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AA371453 Prostate .e 1300 to 1560 1 to 261       261/261
(100 %)
0 diff
(100 %id)
AW962731   .e 1301 to 1792 1 to 489       489/490
(99 %)
31 diff
(93.7 %id)
AA029545 heart .e 1303 to 1562 1 to 261       261/268
(97 %)
2 diff
(99.3 %id)
AW885042 ovary .e 1322 to 1570 21 to 267       247/275
(89 %)
6 diff
(97.9 %id)
BF911687 uterus_tumor .e 1327 to 1843 526 to 12     Submitted on the opposite strand 515/532
(96 %)
0 diff
(100 %id)
AA719764 pineal gland .e 1337 to 1760 424 to 1       424/424
(100 %)
0 diff
(100 %id)
BF690628 melanotic melanoma, high MDR, skin .e 1352 to 2078 1 to 728       728/876
(83 %)
28 diff
(96.9 %id)
AA757577 pineal gland .e 1353 to 1762 410 to 1       410/410
(100 %)
0 diff
(100 %id)
BG771261 adenocarcinoma, Prostate .e 1389 to 2006 110 to 735       626/812
(77 %)
16 diff
(98.1 %id)
R61426 whole brain .e 1395 to 1898 1 to 504       504/504
(100 %)
6 diff
(98.9 %id)
R12106 whole brain .e 1459 to 1865 1 to 410       410/410
(100 %)
3 diff
(99.3 %id)
BG501128 adenocarcinoma, Prostate .e 1468 to 2290 1 to 818       818/818
(100 %)
18 diff
(97.8 %id)
BG770834 adenocarcinoma, Prostate .e 1483 to 2274 1 to 781       781/790
(98 %)
24 diff
(97.0 %id)
AV721455 hypothalamus .e 1487 to 2170 1 to 673       673/673
(100 %)
11 diff
(98.4 %id)
BG118597 adenocarcinoma, cell line, Liver .e 1520 to 2151 1 to 625       625/923
(67 %)
27 diff
(97.1 %id)
BM718008 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1528 to 1786 1 to 259   fully sequenced,   259/259
(100 %)
0 diff
(100 %id)
BG289822 bladder, transitional cell papilloma, cell line .e 1547 to 2309 1 to 759       759/788
(96 %)
17 diff
(97.9 %id)
FN136804 breast carcinoma .e 1560 to 1620 11 to 70       60/71
(84 %)
2 diff
(97.2 %id)
FN160022 breast carcinoma .e 1571 to 1654 1 to 84       84/89
(94 %)
2 diff
(97.8 %id)
DA662083   .e 1608 to 2148 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BF340540 brain, glioblastoma with EGFR amplification .e 1615 to 2386 1 to 768       768/853
(90 %)
32 diff
(96.3 %id)
AV656336 corresponding non cancerous liver tissue .e 1622 to 2043 1 to 422     Submitted on the opposite strand 422/422
(100 %)
3 diff
(99.3 %id)
N34167 melanocyte .e 1626 to 2026 1 to 405       405/405
(100 %)
5 diff
(98.8 %id)
N30486 melanocyte .e 1627 to 2082 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
CK004293 brain/CNS, Human Brain - Cerebellar Cortex .e 1636 to 2261 1 to 625       625/626
(99 %)
3 diff
(99.6 %id)
BX361167 Placenta Cot 25-normalized .e 1639 to 2765 1132 to 10       1123/1132
(99 %)
0 diff
(100 %id)
BP292014 lung .e 1660 to 2240 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BF693497 muscle (skeletal) .e 1669 to 2339 1 to 679       679/680
(99 %)
32 diff
(95.3 %id)
CD677753 eye, Trabecular meshwork .e 1685 to 2345 1 to 661       661/661
(100 %)
1 diff
(99.9 %id)
BX503140 Liver .e 1710 to 2249 1 to 540       540/540
(100 %)
2 diff
(99.7 %id)
BU620803 cell lines, Chondrosarcoma .e 1722 to 2504 800 to 19   AAA   782/782
(100 %)
4 diff
(99.5 %id)
CR593614 Neuroblastoma Cot 25-normalized .e 1736 to 2773 1 to 1038       1038/1038
(100 %)
0 diff
(100 %id)
BX333390 Neuroblastoma Cot 25-normalized .e 1736 to 2802 1 to 1058       1058/1058
(100 %)
13 diff
(98.8 %id)
BM680463 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1756 to 2170 433 to 19   fully sequenced, AAA   415/415
(100 %)
0 diff
(100 %id)
AA329526   .e 1757 to 2092 1 to 338       338/338
(100 %)
2 diff
(99.5 %id)
AA361763   .e 1768 to 2031 1 to 266       266/268
(99 %)
4 diff
(98.6 %id)
CB161190 Liver .e 1796 to 2381 10 to 595       586/595
(98 %)
6 diff
(99.0 %id)
BU620845 cell lines, Chondrosarcoma .e 1809 to 2504 713 to 19   AAA   695/695
(100 %)
1 diff
(99.9 %id)
CA431088 cell lines, Chondrosarcoma .e 1816 to 2504 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
BM724978 eye, fetal eye .e 1824 to 2308 1 to 484   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 484/484
(100 %)
0 diff
(100 %id)
AA282001 germinal center B cell .e 1828 to 2244 1 to 417     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 417/418
(99 %)
1 diff
(99.8 %id)
AA278627 germinal center B cell .e 1836 to 2250 1 to 415   fully sequenced,   415/415
(100 %)
1 diff
(99.8 %id)
AW842534 colon_normal .e 1853 to 2455 625 to 24       602/626
(96 %)
0 diff
(100 %id)
BF091537 testis_normal .e 1855 to 2367 1 to 512       512/512
(100 %)
3 diff
(99.5 %id)
CR738862 germinal center B cell .e 1856 to 2559 1 to 704       704/704
(100 %)
0 diff
(100 %id)
BP240017 Liver .e 1871 to 2431 1 to 560       560/560
(100 %)
12 diff
(97.9 %id)
BM669318 eye, fetal eyes .e 1871 to 2548 696 to 19   AAA   678/678
(100 %)
0 diff
(100 %id)
CB052867 leiomyosarcoma, soft tissue .e 1907 to 2273 17 to 385   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 369/385
(95 %)
17 diff
(95.6 %id)
CN366904 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1926 to 2513 1 to 588       588/588
(100 %)
0 diff
(100 %id)
AA770430   .e 1932 to 2333 402 to 1       402/402
(100 %)
0 diff
(100 %id)
TI_149283797   .e 1934 to 2548 702 to 88   AAA   615/694
(88 %)
1 diff
(99.9 %id)
BM984201 lung, Primary Lung Epithelial Cells .e 1934 to 2548 633 to 19   AAA   615/630
(97 %)
1 diff
(99.9 %id)
FN143884 breast carcinoma .e 1954 to 2016 63 to 1     Submitted on the opposite strand 63/63
(100 %)
2 diff
(96.9 %id)
TI_149309957   .e 1968 to 2802 929 to 102   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 828/982
(84 %)
26 diff
(97.4 %id)
BE645232 pooled .e 1982 to 2548 585 to 19   AAA   567/567
(100 %)
4 diff
(99.3 %id)
EC574948 Prostate .e 2018 to 2143 1 to 124       124/124
(100 %)
4 diff
(96.8 %id)
CB157464 Liver .e 2019 to 2636 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
H40174 brain .e 2023 to 2202 1 to 180       180/180
(100 %)
1 diff
(99.5 %id)
H46838 brain .e 2024 to 2405 1 to 387       387/387
(100 %)
15 diff
(96.2 %id)
BE856520 Prostate .e 2025 to 2509 486 to 2       485/486
(99 %)
0 diff
(100 %id)
BF476361 Prostate .e 2041 to 2509 470 to 2       469/470
(99 %)
0 diff
(100 %id)
CD236907 Pituitary .e 2059 to 2756 1 to 698       698/698
(100 %)
2 diff
(99.8 %id)
AI743373 pooled .e 2065 to 2548 502 to 19   AAA   484/484
(100 %)
2 diff
(99.6 %id)
AW080003 pooled .e 2065 to 2507 446 to 4       443/446
(99 %)
0 diff
(100 %id)
BF941440 brain, glioblastoma (pooled) .e 2066 to 2548 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AI097104 brain, glioblastoma (pooled) .e 2067 to 2549 486 to 4       483/486
(99 %)
0 diff
(100 %id)
AL711860 human skeletal muscle .e 2078 to 2600 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BQ000331 Fibrosarcoma .e 2081 to 2802 741 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 723/723
(100 %)
1 diff
(99.9 %id)
AJ278589 colon .e 2087 to 2317 1 to 231       231/256
(90 %)
1 diff
(99.7 %id)
BQ189527 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2090 to 2538 451 to 1     Submitted on the opposite strand 451/460
(98 %)
23 diff
(95.0 %id)
CK300522 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2090 to 2539 4 to 452     Submitted on the opposite strand 449/460
(97 %)
4 diff
(99.2 %id)
H09719 whole brain .e 2096 to 2548 470 to 17   AAA   454/464
(97 %)
13 diff
(97.2 %id)
BI256654 cervical carcinoma cell line, cervix .e 2096 to 2747 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
AI423504 brain, glioblastoma (pooled) .e 2099 to 2548 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI091575 pooled .e 2106 to 2588 1 to 483     Submitted on the opposite strand 483/483
(100 %)
3 diff
(99.4 %id)
W04668 parathyroid gland, parathyroid tumor .e 2107 to 2278 1 to 172     Submitted on the opposite strand 172/172
(100 %)
1 diff
(99.5 %id)
AI674380 Prostate .e 2127 to 2547 430 to 10       421/430
(97 %)
0 diff
(100 %id)
TI_149280250   .e 2127 to 2816 781 to 94   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 688/1135
(60 %)
13 diff
(98.9 %id)
AA029481 heart .e 2141 to 2391 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AI092275 parathyroid gland, parathyroid tumor .e 2148 to 2548 419 to 19   AAA   401/401
(100 %)
5 diff
(98.8 %id)
AI192998 lung .e 2154 to 2548 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
AA843425 parathyroid gland, parathyroid tumor .e 2181 to 2505 331 to 6       326/331
(98 %)
0 diff
(100 %id)
BM795722 stomach .e 2182 to 2770 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
AA299057 uterus .e 2204 to 2500 1 to 298       298/298
(100 %)
1 diff
(99.7 %id)
AI659546 Prostate .e 2205 to 2548 357 to 14   AAA   344/344
(100 %)
8 diff
(97.7 %id)
AI762252 Kidney .e 2205 to 2509 305 to 1       305/305
(100 %)
7 diff
(97.8 %id)
AA885479 pooled .e 2207 to 2738 534 to 3       532/534
(99 %)
0 diff
(100 %id)
AA868055 pooled .e 2210 to 2505 298 to 3       296/298
(99 %)
0 diff
(100 %id)
AA483843 colon .e 2218 to 2448 232 to 1       232/232
(100 %)
1 diff
(99.6 %id)
AA278628 germinal center B cell .e 2220 to 2550 331 to 1   fully sequenced,   331/331
(100 %)
2 diff
(99.4 %id)
CB052866 leiomyosarcoma, soft tissue .e 2243 to 2812 589 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 570/570
(100 %)
1 diff
(99.9 %id)
AA830249 germinal center B cell .e 2245 to 2729 489 to 5       485/489
(99 %)
0 diff
(100 %id)
AL134147 brain .e 2256 to 2643 31 to 418       388/418
(92 %)
6 diff
(98.6 %id)
BM680191 eye, fetal eye .e 2278 to 2806 546 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 528/528
(100 %)
0 diff
(100 %id)
AW590234 pooled germ cell tumors .e 2282 to 2732 451 to 1       451/451
(100 %)
0 diff
(100 %id)
CR748471 pooled .e 2293 to 2753 1 to 461       461/461
(100 %)
0 diff
(100 %id)
R63310 placenta .e 2293 to 2699 1 to 419       419/422
(99 %)
13 diff
(97.0 %id)
N25567 melanocyte .e 2302 to 2801 503 to 1       503/503
(100 %)
5 diff
(99.1 %id)
AW172424 pooled .e 2302 to 2719 418 to 1       418/418
(100 %)
5 diff
(98.9 %id)
AI699928 pooled germ cell tumors .e 2308 to 2732 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AW983647 head_normal .e 2310 to 2646 35 to 368       334/372
(89 %)
7 diff
(98.2 %id)
BE810254 head_normal .e 2310 to 2639 337 to 9       329/351
(93 %)
0 diff
(100 %id)
BE810246 head_normal .e 2326 to 2646 16 to 335       320/339
(94 %)
17 diff
(95.0 %id)
BJ993578 hepatoblastoma .e 2327 to 2773 446 to 1       446/446
(100 %)
3 diff
(99.4 %id)
AI968635 pooled germ cell tumors .e 2328 to 2702 375 to 1       375/375
(100 %)
1 diff
(99.8 %id)
AA778585   .e 2349 to 2600 252 to 1       252/252
(100 %)
2 diff
(99.3 %id)
AA319692 adrenal gland .e 2368 to 2683 1 to 316       316/316
(100 %)
0 diff
(100 %id)
AA576431 colon, colon tumor RER+ .e 2371 to 2731 361 to 1       361/361
(100 %)
1 diff
(99.8 %id)
N68031 cochlea, ear .e 2373 to 2803 445 to 6       440/460
(95 %)
0 diff
(100 %id)
AI470700 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 2391 to 2738 355 to 8       348/355
(98 %)
0 diff
(100 %id)
AI624069 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 2394 to 2730 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
R36860 whole brain .e 2433 to 2794 396 to 28   AAA   369/377
(97 %)
0 diff
(100 %id)
AW983574 head_normal .e 2441 to 2631 209 to 16     Submitted on the opposite strand 194/209
(92 %)
0 diff
(100 %id)
AW609818 stomach .e 2447 to 2698 14 to 265       252/265
(95 %)
6 diff
(97.8 %id)
N52758 multiple sclerosis lesions .e 2487 to 2803 321 to 1       321/329
(97 %)
11 diff
(96.7 %id)
AA280617 germinal center B cell .e 2501 to 2820 333 to 14   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 320/320
(100 %)
0 diff
(100 %id)
FN106489 breast carcinoma .e 2504 to 2599 96 to 1     Submitted on the opposite strand 96/96
(100 %)
2 diff
(98.0 %id)
AA369839 Prostate .e 2511 to 2802 292 to 1       292/292
(100 %)
1 diff
(99.7 %id)
AA768638 germinal center B cell .e 2520 to 2802 301 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 283/283
(100 %)
0 diff
(100 %id)
AI758489 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 2544 to 2802 277 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 259/259
(100 %)
1 diff
(99.7 %id)
Z39839 brain, total brain .e 2547 to 2793 256 to 10       247/256
(96 %)
0 diff
(100 %id)
R16041 whole brain .e 2551 to 2794 268 to 26   AAA   243/251
(96 %)
0 diff
(100 %id)
H40110 brain .e 2551 to 2805 257 to 2       256/257
(99 %)
0 diff
(100 %id)
AA809759 germinal center B cell .e 2557 to 2802 271 to 26   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 246/246
(100 %)
0 diff
(100 %id)
AI184905 pooled .e 2562 to 2802 262 to 22   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 241/241
(100 %)
0 diff
(100 %id)
R37936 whole brain .e 2591 to 2794 238 to 36   AAA   203/211
(96 %)
0 diff
(100 %id)
EH352608   .e 2659 to 2737 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
AW304327 lung, two pooled squamous cell carcinomas .e 2677 to 2803 132 to 6       127/132
(96 %)
0 diff
(100 %id)
AA885041 pooled .e 2733 to 2802 85 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 70/70
(100 %)
0 diff
(100 %id)
CD656370 Embryonic Stem cells .f 1 to 799 6 to 800 G2R Q231S A238X E240* tiling clone,   795/808
(98 %)
16 diff
(98.1 %id)
BU616789 Cell Line, Chondrosarcoma .f 104 to 809 724 to 19   tiling clone, AAA   706/706
(100 %)
1 diff
(99.9 %id)
BX361168 Placenta Cot 25-normalized .g 1 to 968 1 to 965 E30K K31N L32* tiling clone,   965/974
(99 %)
7 diff
(99.3 %id)
BQ311908 breast_normal .g 368 to 744 1 to 386       386/386
(100 %)
20 diff
(94.9 %id)
BI561015 testis .h 1 to 702 1 to 709 exact tiling clone,   709/904
(78 %)
13 diff
(98.6 %id)
TI_44349250   .h 6 to 702 90 to 793 exact     704/988
(71 %)
15 diff
(98.5 %id)
DA347095 substantia nigra .i 1 to 551 2 to 553 F32X T33Y I34Y K35Q W36M ... tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
CD685852 normal nasopharynx .j 1 to 592 38 to 630 I41M I62M L116S tiling clone,   593/630
(94 %)
11 diff
(98.3 %id)
DC314725 amygdala .k 1 to 585 1 to 586 exact tiling clone,   586/586
(100 %)
2 diff
(99.7 %id)
BX508666   .l 1 to 538 1 to 539   tiling clone,   539/539
(100 %)
1 diff
(99.9 %id)
DB111399 thymus .l 229 to 797 2 to 571   tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
DB343358 thymus .l 2084 to 2598 516 to 1   tiling clone,   516/516
(100 %)
2 diff
(99.7 %id)
AA215401 germinal center B cell .m-u 1 to 131 1 to 132   tiling clone, to resequence,   132/135
(97 %)
3 diff
(97.8 %id)
AW594418 pooled germ cell tumors .m-u 1659 to 2061 406 to 1   tiling clone,   406/406
(100 %)
3 diff
(99.3 %id)
DA128380 cerebellum .m-u 1711 to 2289 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
BU688311 lung .m-u 3030 to 3661 650 to 19 H22Y tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 632/632
(100 %)
3 diff
(99.6 %id)
BM969905 lung, Primary Lung Epithelial Cells .m-u 3057 to 3675 636 to 19 H22Y AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 618/618
(100 %)
4 diff
(99.4 %id)
BQ007058 Chondrosarcoma, Left Pelvis .m-u 3062 to 3661 618 to 19 H22Y tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 600/600
(100 %)
2 diff
(99.7 %id)
AW070331 pooled .m-u 3081 to 3662 585 to 4 H22Y tiling clone,   582/585
(99 %)
0 diff
(100 %id)
CB159688 Liver .m-u 3106 to 3658 1 to 553 exact     553/553
(100 %)
0 diff
(100 %id)
BF594806 Kidney .m-u 3109 to 3673 569 to 5 L8X     565/569
(99 %)
0 diff
(100 %id)
TI_149275664   .m-u 3111 to 3661 637 to 87 H22Y AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 551/999
(55 %)
5 diff
(99.5 %id)
BU676728 lung, Primary Lung Epithelial Cells .m-u 3111 to 3661 569 to 19 H22Y AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 551/553
(99 %)
5 diff
(99.1 %id)
AI808635 pooled .m-u 3138 to 3662 528 to 4 exact     525/528
(99 %)
0 diff
(100 %id)
DB300955 cerebellum .m-u 3139 to 3679 542 to 1 exact     542/542
(100 %)
1 diff
(99.9 %id)
AI808760 pooled .m-u 3139 to 3662 527 to 4 exact     524/527
(99 %)
0 diff
(100 %id)
BP326271 prostata .m-u 3149 to 3728 1 to 575 V49X E50G V51X S52X G53R ... tiling clone,   575/581
(98 %)
7 diff
(98.8 %id)
BP392215 pancreatic islet .m-u 3162 to 3661 1 to 501 S42X C43L T44Y L45F N46E ...   Submitted on the opposite strand 501/501
(100 %)
1 diff
(99.9 %id)
AI806642 pooled .m-u 3165 to 3679 529 to 15 M20I AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 515/515
(100 %)
3 diff
(99.5 %id)
AW664415 2 pooled high-grade transitional celltumors, genitourinary tract .m-u 3167 to 3681 515 to 1 exact tiling clone,   515/515
(100 %)
0 diff
(100 %id)
AI263892 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m-u 3192 to 3676 485 to 1 exact     485/485
(100 %)
1 diff
(99.8 %id)
AI687290 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m-u 3193 to 3661 469 to 1 H22Y     469/469
(100 %)
1 diff
(99.8 %id)
AI660637 colon, colonic mucosa from 5 ulcerative colitispatients .m-u 3194 to 3661 482 to 15 H22Y AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 468/468
(100 %)
1 diff
(99.8 %id)
DA357922 subthalamic nucleus .m-u 3195 to 3749 2 to 556 H22Y tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
AI218017 pooled .m-u 3199 to 3661 481 to 19 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 463/463
(100 %)
1 diff
(99.8 %id)
AI425096 pooled .m-u 3216 to 3662 449 to 3 exact     447/449
(99 %)
0 diff
(100 %id)
AI950490 lung, two pooled squamous cell carcinomas .m-u 3230 to 3662 441 to 7 exact     435/441
(98 %)
0 diff
(100 %id)
F34735 pectoral muscle (after mastectomy) .m-u 3238 to 3637 1 to 400 exact     400/409
(97 %)
1 diff
(99.8 %id)
AA659932 normal prostate, Prostate .m-u 3247 to 3661 417 to 1 exact     417/417
(100 %)
2 diff
(99.6 %id)
AA789184   .m-u 3250 to 3661 412 to 1 exact     412/413
(99 %)
0 diff
(100 %id)
BE139484 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 3253 to 3662 410 to 1 H22Y     410/410
(100 %)
2 diff
(99.6 %id)
W31769 parathyroid gland, parathyroid tumor .m-u 3254 to 3662 415 to 6 H22Y   Submitted on the opposite strand 410/415
(98 %)
0 diff
(100 %id)
AI742264 pooled .m-u 3266 to 3754 497 to 9 E54D     489/497
(98 %)
0 diff
(100 %id)
BP386360 pancreatic islet .m-u 3268 to 3660 1 to 394 S15L K16*   Submitted on the opposite strand 394/394
(100 %)
2 diff
(99.5 %id)
BQ640070 eye, retina .m-u 3281 to 3675 9 to 404 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 396/404
(98 %)
6 diff
(98.6 %id)
AA749063 germinal center B cell .m-u 3284 to 3661 402 to 25 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
BX097401 whole brain .m-u 3286 to 3662 390 to 14 H22Y     377/390
(96 %)
0 diff
(100 %id)
BQ005328 Chondrosarcoma, Left Pelvis .m-u 3291 to 3661 387 to 19 L8Y L9C Y10I F11S F12L ... AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 369/369
(100 %)
3 diff
(99.2 %id)
AA768824 germinal center B cell .m-u 3303 to 3661 388 to 30 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 359/359
(100 %)
0 diff
(100 %id)
AA907350 pooled .m-u 3303 to 3681 382 to 4 M20I     379/382
(99 %)
0 diff
(100 %id)
AI216029 pooled .m-u 3326 to 3662 340 to 4 H22Y     337/341
(98 %)
0 diff
(100 %id)
AI005582   .m-u 3329 to 3661 343 to 11 H22Y AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 333/333
(100 %)
1 diff
(99.7 %id)
AW196635 adenocarcinoma, Pancreas .m-u 3336 to 3680 345 to 1 G48R     345/345
(100 %)
2 diff
(99.5 %id)
AA215402 germinal center B cell .m-u 3546 to 3681 141 to 6   to resequence,   136/141
(96 %)
0 diff
(100 %id)
DA823461 pericardium .n-u 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DB063801 testis .n-u 109 to 623 2 to 516   tiling clone, capped   515/515
(100 %)
0 diff
(100 %id)
AV734580 pheochromocytoma Gene ATAD1, variant not shown         Suspected internal deletion, this clone was ignored    
AV650386 corresponding non cancerous liver tissue Gene ATAD1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB538407 hippocampus Gene ATAD1, variant not shown         Submitted on the opposite strand    
T62480 lung Gene ATAD1, variant not shown         This clone was ignored    
T62625 lung Gene ATAD1, variant not shown         This clone was ignored    
AI005677   Gene ATAD1, variant not shown         Suspected internal deletion, this clone was ignored    
BF790614 muscle (skeletal) Gene ATAD1, variant not shown              
BG026204 Bone, osteosarcoma, cell line Gene ATAD1, variant not shown       available from MGC, This clone was ignored    
DA717968   Gene ATAD1, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB216197 trachea Gene ATAD1, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI